
Divisional Vice President Medical, Clinical and Scientific Affairs ID Rapid Diagnostics
Global medical affairs leader with proven technical and organizational track record, passionate for quality innovation and rapid diagnostics, having worked from the US, EMA, and Asia in roles of broad influence and scientific accountability. Lead and managed global healthcare-related organizations leaving each more capable, highly engaged, and diverse. Provides strong medical leadership developing Medical, Clinical and Scientific Affairs Strategy aligned to business, clinical development, and customer needs. Develop and execute Integrated Medical Affairs Plan responsible for all pipeline and marketed products. Provides strategic insights to business for expansion of the organization’s expertise in the diagnostic industry and a competitive advantage in the marketplace. In addition to providing medical and scientific expertise to support Innovation, New Product Development safety and efficacy, Product lifecycle management and post-market product safety, plays a key leadership role in Clinical market shaping efforts such as development of education tools, clinical and laboratory professional services, scientific symposia, advisory boards, publications while ensuring the functional excellence of diverse and inclusive, high performing teams globally. Strong advocate of patient and healthcare worker safety, a recognized thought leader and proactive medical professional with a career of almost three decades reflecting leadership skills coupled with hands-on experience in Laboratory Medicine (Clinical diagnostic and research laboratories network) and Medical Affairs in Medical Device – In Vitro Diagnostics. Well recognized as a strong proponent of diversity, equity, and inclusion in workplace as well as Clinical research ensuring data generated for registrational trials is as diverse as the population effected by the disease state. Have been involved in multiple Global Health projects in Africa, Asia, CIS countries to advance health equity globally.Â